NT-proBNP and hscTnT in Predicting the Incidence and Prognosis of Anthracycline-Caused Cardiovascular Toxicities in Non-Hodgkin's Lymphoma
Clinical Laboratory · 2026 · 72 (03/2026)
DOI: 10.7754/clin.lab.2025.240339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Guangjian Su und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Anthracyclines, Troponin T, Peptide Fragments.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Su, G., Peng, W., Chen, Y., Lin, Y., Chen, J., Xiao, Y., Cui, Z., & Xiao, Z. (2026). NT-proBNP and hscTnT in Predicting the Incidence and Prognosis of Anthracycline-Caused Cardiovascular Toxicities in Non-Hodgkin's Lymphoma. Clinical Laboratory, 72(03/2026). https://doi.org/10.7754/clin.lab.2025.240339
Vancouver
Su G, Peng W, Chen Y, Lin Y, Chen J, Xiao Y, et al. NT-proBNP and hscTnT in Predicting the Incidence and Prognosis of Anthracycline-Caused Cardiovascular Toxicities in Non-Hodgkin's Lymphoma. Clinical Laboratory. 2026;72(03/2026). doi:10.7754/clin.lab.2025.240339
BibTeX
@article{Su2026,
author = {Su, Guangjian and Peng, Wei and Chen, Yan and Lin, Yingfeng and Chen, Jin and Xiao, Yanping and Cui, Zhaolei and Xiao, Zhenzhou},
title = {NT-proBNP and hscTnT in Predicting the Incidence and Prognosis of Anthracycline-Caused Cardiovascular Toxicities in Non-Hodgkin's Lymphoma},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {03/2026},
doi = {10.7754/clin.lab.2025.240339}
}
EUVIMED